Grant: Team Grant: Canadian Microbiome Initiative 2: Research Teams - IHDCYH Pool
University of British Columbia
$2,000,000.00
Role of microbes in the pathogenesis of PIBD: From discovery, through causation, to novel treatments
EF 2019-20
Résumé
Inflammatory bowel diseases (IBD) are chronic conditions that damage a person's intestines and cause lifelong pain. IBD is becoming more common in Canada, especially in children. Current treatments (drugs) suppress patient's immune systems and don't work all the time;
even when they work they carry substantial risks. Therefore, we need to develop new treatments. While studying some of our patients, our Team of doctors and scientists has found several types of unusual bacteria in their intestines. These bacteria are able to attach to - or invade the cells lining the human gut, and trigger inflammation. These bacteria are also
recognized by the patient's immune cells, suggesting these "pathobiont" bacteria are involved in either causing IBD, or making it worse, and thus removing these nasty bacteria could be a new treatment for IBD.
Our Team is part of a national Network studying IBD in more than 1500 Canadian children. We plan to use the existing Network infrastructure to collect samples from these patients, including stool samples, intestinal washing, and tissues. We will use specialized techniques to identify potential "pathobionts" and grow them up in large numbers, allowing us to study them in great detail. We will test how they stick or invade human cells grown in the lab, as well as inject them into mice to see how they cause disease. As we gain a better understanding of how different "pathobiont" bacteria cause disease, we will develop new ways to target these bacteria and test these approaches in the lab, in mouse models, and ultimately in the patients themselves. For example, we will test if certain diets can starve these bacteria, if there are specific good bacteria we can give to patients in their food that can outcompete the pathobionts, or if we can use new drugs to kill, or flush away these harmful bacteria. Taken
together, our studies will help develop new precise and personalized ways to treat children with IBD, and ultimately improve their lives.
Programme
Team Grant: Canadian Microbiome Initiative 2: Research Teams - IHDCYH Pool
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
417360
Name
Vallance Bruce A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Team Grant : Canadian Microbiome Initiative 2: Research Teams
Projecttitle
Role of microbes in the pathogenesis of PIBD: From discovery, through causation, to novel treatments
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$2,000,000
Cihrequipment2
$0
Programname2
Team Grant: Canadian Microbiome Initiative 2: Research Teams - IHDCYH Pool
Keyworddelim
Children; Inflammatory Bowel Disease; Microbiome; Mucus; Multi-Omics; Nutrition; Organoids; Pathobionts; Pediatrics; Therapeutic Interventions
Abstract
Inflammatory bowel diseases (IBD) are chronic conditions that damage a person's intestines and cause lifelong pain. IBD is becoming more common in Canada, especially in children. Current treatments (drugs) suppress patient's immune systems and don't work all the time;
even when they work they carry substantial risks. Therefore, we need to develop new treatments. While studying some of our patients, our Team of doctors and scientists has found several types of unusual bacteria in their intestines. These bacteria are able to attach to - or invade the cells lining the human gut, and trigger inflammation. These bacteria are also
recognized by the patient's immune cells, suggesting these "pathobiont" bacteria are involved in either causing IBD, or making it worse, and thus removing these nasty bacteria could be a new treatment for IBD.
Our Team is part of a national Network studying IBD in more than 1500 Canadian children. We plan to use the existing Network infrastructure to collect samples from these patients, including stool samples, intestinal washing, and tissues. We will use specialized techniques to identify potential "pathobionts" and grow them up in large numbers, allowing us to study them in great detail. We will test how they stick or invade human cells grown in the lab, as well as inject them into mice to see how they cause disease. As we gain a better understanding of how different "pathobiont" bacteria cause disease, we will develop new ways to target these bacteria and test these approaches in the lab, in mouse models, and ultimately in the patients themselves. For example, we will test if certain diets can starve these bacteria, if there are specific good bacteria we can give to patients in their food that can outcompete the pathobionts, or if we can use new drugs to kill, or flush away these harmful bacteria. Taken
together, our studies will help develop new precise and personalized ways to treat children with IBD, and ultimately improve their lives.
Competitiondate
201909
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Vallance, Bruce A; Griffiths, Anne Marie; Mack, David R; Muise, Aleixo M; Parkinson, John; Ricciuto, Amanda; Surette, Michael G; Tropini, Carolina; Wine, Eytan
Approvedterm
5 ans 0 mois
Cihrcontribution2
Inst of Human Dev &Child &Yth~ $1,577,000~ $0~Institute of Aging~ $423,000~ $0~